Leslie RG - Search Results

1

The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.

Olesen EH, Johnson AA, Damgaard G, Leslie RG. Olesen EH, et al. Among authors: leslie rg. Immunology. 1998 Feb;93(2):177-83. doi: 10.1046/j.1365-2567.1998.00429.x. Immunology. 1998. PMID: 9616366 Free PMC article.

2

A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement system.

Marquart HV, Olesen EH, Johnson AA, Damgaard G, Leslie RG. Marquart HV, et al. Among authors: leslie rg. Scand J Immunol. 1997 Sep;46(3):246-53. doi: 10.1046/j.1365-3083.1997.d01-122.x. Scand J Immunol. 1997. PMID: 9315112 Free article.

3

The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras.

Johnson AA, Mirowski Rosengard A, Skjodt K, Ahearn JM, Leslie RG. Johnson AA, et al. Among authors: leslie rg. Eur J Immunol. 1999 Dec;29(12):3837-44. doi: 10.1002/(SICI)1521-4141(199912)29:12<3837::AID-IMMU3837>3.0.CO;2-K. Eur J Immunol. 1999. PMID: 10601991 Free article.

4

The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.

Leslie RG. Leslie RG. Immunology. 1999 Jul;97(3):371-3. doi: 10.1046/j.1365-2567.1999.00846.x. Immunology. 1999. PMID: 10447756 Free PMC article.

5

CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes.

Nielsen CH, Marquart HV, Prodinger WM, Leslie RG. Nielsen CH, et al. Among authors: leslie rg. Immunology. 2001 Dec;104(4):418-22. doi: 10.1046/j.1365-2567.2001.01325.x. Immunology. 2001. PMID: 11899427 Free PMC article.

6

CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.

Marquart HV, Svehag SE, Leslie RG. Marquart HV, et al. Among authors: leslie rg. J Immunol. 1994 Jul 1;153(1):307-15. J Immunol. 1994. PMID: 7515925

7

Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL).

Marquart HV, Grønbaek K, Christensen BE, Svehag SE, Leslie RG. Marquart HV, et al. Among authors: leslie rg. Clin Exp Immunol. 1995 Dec;102(3):575-81. doi: 10.1111/j.1365-2249.1995.tb03855.x. Clin Exp Immunol. 1995. PMID: 8536375 Free PMC article.

8

Complement-activating ability of leucocytes from patients with complement factor I deficiency.

Marquart HV, Rasmussen JM, Leslie RG. Marquart HV, et al. Among authors: leslie rg. Immunology. 1997 Jul;91(3):486-92. doi: 10.1046/j.1365-2567.1997.00273.x. Immunology. 1997. PMID: 9301541 Free PMC article.

9

Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE).

Marquart HV, Svendsen A, Rasmussen JM, Nielsen CH, Junker P, Svehag SE, Leslie RG. Marquart HV, et al. Among authors: leslie rg. Clin Exp Immunol. 1995 Jul;101(1):60-5. doi: 10.1111/j.1365-2249.1995.tb02277.x. Clin Exp Immunol. 1995. PMID: 7621593 Free PMC article.

10

Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments.

Løbner M, Leslie RG, Prodinger WM, Nielsen CH. Løbner M, et al. Among authors: leslie rg. Immunology. 2009 Sep;128(1 Suppl):e661-9. doi: 10.1111/j.1365-2567.2009.03056.x. Epub 2009 Jan 23. Immunology. 2009. PMID: 19740327 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters